News
STEMscopes Science is one of only five science programs on Evidence for ESSA, which provides information on programs meeting ...
XenoTherapeutics has agreed to acquire Essa Pharma in a deal that is structured and financed by biotechnology royalty aggregator XOMA Royalty.
Essa Pharma, which had been resisting pressure from activist investors to wind down operations, has now agreed a deal to ...
8hon MSN
Indiana is proposing a significant shift in education funding, seeking federal approval to consolidate various streams into ...
ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that it has entered into a definitive agreement (the "Business Combination Agreement") with XenoTherapeutics, Inc. ("Xeno"), ...
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ESSA Pharma Inc. (NASDAQ: EPIX) to XenoTherapeutics, Inc. is fair to ESSA shareholders.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ESSA Pharma Inc. (NASDAQ: EPIX) to XenoTherapeutics, Inc. is fair to ESSA shareholders.
Headquartered in Stroudsburg, ESSA Bancorp Inc., the parent company of ESSA Bank & Trust, is being acquired by CNB Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results